Hyperglycemia to nephropathy via transforming growth factor beta

Area of Science:

• Nephrology
• Endocrinology
• Molecular Biology

Background:

• Diabetic nephropathy (DN) is a leading cause of end-stage renal disease.
• Hyperglycemia in diabetes mellitus significantly contributes to DN pathogenesis.
• Transforming growth factor beta (TGF-β) is increasingly recognized as a central mediator in DN.

Purpose of the Study:

• To elucidate the molecular mechanisms linking hyperglycemia to diabetic nephropathy.
• To highlight the pivotal role of transforming growth factor beta (TGF-β) in DN progression.
• To provide a schematic overview for understanding and managing diabetic nephropathy.

Main Methods:

• Review of existing literature on diabetic nephropathy pathogenesis.
• Analysis of molecular pathways activated by hyperglycemia.
• Focus on the role of TGF-β and its downstream effectors.

Main Results:

• Hyperglycemia upregulates TGF-β gene, protein, and receptor expression.
• Multiple pathways (polyol, PKC, hexosamine, AGEs, oxidative stress) mediate hyperglycemia's effect on TGF-β.
• Activated TGF-β promotes glomerular basement membrane thickening and glomerulosclerosis via CTGF and VEGF.

Conclusions:

• Transforming growth factor beta (TGF-β) is a critical molecular link between hyperglycemia and diabetic nephropathy.
• Understanding the TGF-β pathway offers potential therapeutic targets for DN management.
• A clear understanding of these mechanisms is essential for preventing diabetic kidney disease progression.